Showing results (1251-1260 of 1,842) with videos related to
Sort By:
Pageof 185
Journal of Managed Care & Specialty Pharmacy|September 26, 2025
AMCP Market Insights: Navigating the rapidly changing landscape of ER+/HER2- metastatic breast cancerBridget Flavin, Denise Wolff, Laura Bobolts, et al.Journal of Managed Care & Specialty Pharmacy|September 26, 2025
Associations of oseltamivir with neuropsychiatric and behavioral adverse events: A systematic review and meta-analysisHye Su Jeong, Yeo Wool Lee, Taeho Greg Rhee, et al.Journal of Managed Care & Specialty Pharmacy|July 31, 2025
A structured approach for identifying disease analogs for pulmonary arterial hypertensionKarim El-Kersh, Nadine Zawadzki, Anna Watzker, et al.Journal of Managed Care & Specialty Pharmacy|August 25, 2021
Real-world evidence for option value in metastatic melanomaWilliam B Wong, Tu My To, Meng Li, et al.Journal of Managed Care & Specialty Pharmacy|August 2, 2021
Factors associated with medication nonadherence among Medicare low-income subsidy beneficiaries with diabetes, hypertension, and/or heart failureChi Chun Steve Tsang, Jamie Browning, Lorraine Todor, et al.Journal of Managed Care & Specialty Pharmacy|August 2, 2021
Patient characteristics associated with use of TNF vs interleukin inhibitors as first-line biologic treatment for psoriatic arthritisYinzhu Jin, Sarah K Chen, Hemin Lee, et al.Journal of Managed Care & Specialty Pharmacy|August 2, 2021
Optimal treatment sequence for targeted immune modulators for the treatment of moderate to severe ulcerative colitisLisa M Bloudek, Rajshree Pandey, Katherine Fazioli, et al.Journal of Managed Care & Specialty Pharmacy|July 11, 2025
AMCP Market Insights: Impact of the evolving understanding of multiple sclerosis and emerging treatment approaches on managed careBridget Flavin, Justin Bioc, Janna Evans, et al.Journal of Managed Care & Specialty Pharmacy|July 24, 2025
Real-time continuous glucose monitoring vs self-monitoring of blood glucose in distinct multi-ethnic cohorts of patients living with insulin-treated type 2 diabetes in the United States: A cost-utility analysis from a Medicare perspectiveHamza Alshannaq, Jessica Matuoka, Richard F Pollock, et al.Journal of Managed Care & Specialty Pharmacy|June 27, 2025
Health care resource utilization and costs in Medicare Advantage beneficiaries using glucagon-like peptide-1 receptor agonists vs sodium-glucose cotransporter-2 inhibitorsInsiya B Poonawalla, Petir Abdal, Mary Hayes, et al.Pageof 185